Compare Microchip Technology Inc. (MCHP) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microchip Technology Inc. vs Stryker Corporation — how do they compare? Microchip Technology Inc. trades at $75.55 (market cap $41.01B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 2.6× Microchip Technology Inc.'s market cap, and Microchip Technology Inc. pays the higher dividend (2.41%). Which is the better fit depends on your goals — on Pluang, investors hold Microchip Technology Inc. for 63 Days and Stryker Corporation for 21 Days on average.
| MCHP | SYK | |
|---|---|---|
Market Cap | $41.01B | $106.24B |
Volume | 9,972,516 | 2,982,001 |
Sector | Technology | Health |
52-Week High | $102.97 | $388.35 |
52-Week Low | $49.02 | $269.75 |
Typical Hold Time | 63 Days | 21 Days |
Enterprise Value | $46.13B | $117.70B |
Dividend Yield | 2.41% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MCHP trades at $75.52, down 3.2% over 24 hours, with technical indicators showing a bearish trend. The company reported a net loss of -$500K in 2025, though it has consistently beaten EPS estimates in recent quarters. Recent news highlights expansion in Ethernet and 48V power portfolios, including the acquisition of Hailo, targeting automotive and industrial demand. Analyst consensus is strongly bullish with a $110.50 price target, but high valuation ratios and significant debt pose risks.
The outlook is mixed: strong analyst support and strategic expansions in AI and data centers offer growth potential, but high P/E of 111.06 and net income margin pressure from 2025 raise concerns. Investors face upside from earnings beats and sector demand against valuation and cyclical semiconductor risks.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
